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Inhibition of autophagic proteolysis by hypoosmotic
or amino acid-induced hepatocyte swelling requires os-
mosignaling toward p38MAPK; however, the upstream os-
mosensing and signaling events are unknown. These
were studied in the intact perfused rat liver with a pre-
served in situ environment of hepatocytes. It was found
that hypoosmotic hepatocyte swelling led to an activa-
tion of Src (but not FAK), Erks, and p38MAPK, which was
prevented by the integrin inhibitory hexapeptide
GRGDSP, but not its inactive analogue GRGESP. Src
inhibition by PP-2 prevented hypoosmotic MAP kinase
activation, indicating that the integrin/Src system is lo-
cated upstream in the osmosignaling toward p38MAPK
and Erks. Inhibition of the integrin/Src system by the
RGD motif-containing peptide or PP-2 also prevented
the inhibition of proteolysis and the decrease in auto-
phagic vacuole volume, which is otherwise observed in
response to hypoosmotic or glutamine/glycine-induced
hepatocyte swelling. These inhibitors, however, did not
affect swelling-independent proteolysis inhibition by
phenylalanine. In line with a role of p38MAPK in trigger-
ing the volume regulatory decrease (RVD), PP-2 and the
RGD peptide blunted RVD in response to hypoosmotic
cell swelling. The data identify integrins and Src as up-
stream events in the osmosignaling toward MAP ki-
nases, proteolysis, and RVD. They further point to a role
of integrins as osmo- and mechanosensors in the intact
liver, which may provide a link between cell volume and
cell function.
Changes in cell hydration within a narrow, physiological
range markedly affect carbohydrate and protein metabolism,
hepatic bile flow, gene expression, and cellular susceptibility to
environmental stress (1–6). The regulation of cell function by
cell hydration requires structures, which sense hydration
changes (osmosensing) and intracellular signaling pathways
toward effector sites (osmosignaling).
Progress has been made in identifying signal transduction
pathways linking cell volume changes to alterations in cell
function (7). For example, the MAPK,1 p38MAPK, activation is
critical for creating volume-regulatory ion fluxes in response to
hypoosmotic swelling in perfused rat liver (8) and HTC liver
cells (9). Likewise, proteolysis inhibition by cell swelling
strongly depends on activation of the p38MAPK in perfused rat
liver (10). Specific inhibition of the p38MAPK abolishes the
antiproteolytic effects exerted by hypoosmolarity and gluta-
mine, but is without effect on cell swelling under these condi-
tions (10). Another component involved in swelling-dependent
proteolysis inhibition is the microtubular system. Colchicine
blocks hypoosmotic proteolysis inhibition, but not p38MAPK ac-
tivation upon hypoosmolarity (11). These data show that the
microtubule-dependent element in hydration-dependent prote-
olysis signaling is obviously localized downstream of p38MAPK
activation. In contrast to agonists that cause changes of cell
hydration, the antiproteolytic action of non-swelling amino ac-
ids, e.g. phenylalanine, resides on the activation of other sig-
naling events, such as activation of mammalian target of rapa-
mycin (mTOR) and p70 ribosomal S6 protein kinase (p70S6K
kinase) (12–14), which can clearly be differentiated from the
swelling-related antiproteolytic signaling cascade (15).
Whereas in bacteria, plants, and fungi two-component histi-
dine kinases were identified to be involved in sensing of and
subsequent adaptation to adverse osmotic conditions (16), the
mechanisms of osmosensing in mammalian cells are far from
being understood. Integrins are candidates to be involved in
mechanotransduction, i.e. the conversion of a mechanical stim-
ulus into covalent modifications of signaling components. Inte-
grins are heterodimers with each subunit having a single
transmembrane domain. They establish cell adhesion to the
extracellular matrix and bind inside the cell to cytoplasmic
proteins, which in turn interact with different signal transduc-
tion components and the cytoskeleton (for reviews see Refs. 17
and 18). In normal liver, the most important integrins are 11,
51, and 91 (19–21).
The present study investigates the role of integrins and Src
in hypoosmotic signaling toward proteolysis inhibition and cell
volume regulation in the isolated perfused rat liver, which most
authentically represents the three-dimensional hepatocyte an-
choring to the extracellular matrix, preserved cell polarity,
intact cytoskeleton, and structural/functional cell-cell interac-
tions. Using the integrin antagonistic peptide GRGDSP and
the Src kinase inhibitor PP-2, an integrin-dependent activation
of Src kinases was localized upstream of swelling-induced
p38MAPK signaling toward inhibition of autophagy. In contrast,
the antiproteolytic effect of phenylalanine, which does not in-
volve cell swelling and p38MAPK does not depend on GRGDSP-
sensitive integrin action and Src activation. Consistent with
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inhibition of osmosignaling toward p38MAPK, GRGDSP and
PP2 effectively antagonize the volume regulatory response trig-
gered by hypoosmotic swelling. The findings suggest a role of
integrins in hepatic osmosensing and transforming hepatocyte
swelling into a physiological response.
EXPERIMENTAL PROCEDURES
Liver Perfusion—Livers from male Wistar rats (160–230 g), fed a
standard diet, were perfused in an open non-recirculating manner at a
flow rate of 3.5–4.5 ml/min/g. The perfusion medium was bicarbonate-
buffered Krebs-Henseleit saline plus lactate (2.1 mmol/liter) and pyru-
vate (0.3 mmol/liter), incubated with O2/CO2 (19:1, v/v), at a tempera-
ture of 37 °C. For changing the osmolarity, the NaCl concentration (115
mmol/liter) was varied, resulting in corresponding changes of osmolar-
ity. Additions were made either by the use of micropumps (20 l/min) or
by dissolution in Krebs-Henseleit buffer. Inhibitors were dissolved in
Me2SO. Viability of the livers was assessed by monitoring effluent
oxygen concentration and measurement of lactate dehydrogenase leak-
age from livers, which did not exceed 15–20 milliunits/min/g of liver.
Monitoring and Assays in Liver Perfusion—Effluent perfusate pH
was monitored continuously with a pH-sensitive electrode, and the
perfusion pressure was detected by a pressure transducer (Hugo Sachs
Electronics, Hugstetten, Germany). Basal portal pressure was 3–5 cm
H2O and was not affected by the compounds used in this study. The
intracellular water space was calculated from the difference of washout
profiles of simultaneously infused [14C]urea and [3H]inulin as described
previously (22). In fed animals, the cell water under control conditions
was 551  10 l/g (n  28). Proteolysis was determined in separate
perfusion experiments as 3H label release from rats that had been
injected intraperitoneally with 50 Ci of L-4,5-[3H]leucine 16 h prior to
the perfusion experiment as described previously (23). The rate of
proteolysis was set to 100% under normotonic control conditions, due to
different labeling of hepatic proteins after intraperitoneal injection, and
the extent of inhibition of proteolysis was determined 30 min after
institution of the respective condition, a time point, when a new steady
state had been reached.
In bile experiments, livers were perfused with 100 mol/liter
[3H]taurocholate (1 Ci/liter). Bile was collected at 2-min intervals. Bile
flow was assessed by gravimetry, assuming a specific mass of 1 g/ml.
Taurocholate excretion into bile was determined by liquid scintillation
counting of the radioactivity present in bile, based on the specific
radioactivity of [3H]taurocholate in influent perfusate.
Preparation of Cultured Hepatocytes—Liver parenchymal cells were
isolated from the livers of male Wistar rats (200 g body wt.) by colla-
genase perfusion as described previously by Meijer et al. (24). The cells
were plated on fibronectin-coated culture dishes (17 g/dish, diameter
60 mm, 1  106 cells) and maintained in Krebs-Henseleit buffer
(KHB) with 6 mmol/liter glucose, equilibrated in a humidified atmo-
sphere (air/CO2, 19:1, v/v) at 37 °C. After 4 h in KHB, the cells were
cultured for another 48 h in Dulbecco’s modified Eagle’s medium
(DMEM) containing 5% fetal calf serum and 1% penicillin/streptomycin,
insulin (100 nmol/liter), 1% glutamine, dexamethasone (100 nmol/liter),
sodium selenite (30 nmol/liter), and aprotinin (1 g/ml). Fresh DMEM
was added after 24 h. After a total cultivation time of 48 h, cells were
cultured in normoosmotic DMEM without additions containing 1000
mg/liter glucose for 4 h. After starvation for 4 h in normoosmotic
medium, cells were either exposed to hypoosmolar (205 mosmol/liter) or
normoosmotic control medium (305 mosmol/liter) for 2 min. If indicated,
cells were incubated with PP-2 (20 mol/liter) or GRGDSP (250 mol/
liter) 20 min prior to installing hypoosmolarity or the normoosmotic
control condition, respectively. At the end of experimental treatment,
medium was removed from the culture, and cells were immediately
lysed at 4 °C using lysis buffer containing 20 mmol/liter Tris-HCl (pH
7.4), 140 mmol/liter NaCl, 10 mmol/liter NaF, 10 mmol/liter sodium
pyrophosphate, 1% Triton X-100, 1 mmol/liter EDTA, 1 mmol/liter
EGTA, 1 mmol/liter sodium vanadate, 20 mmol/liter -glycerophos-
phate, and protease inhibitor mixture (Roche Applied Science). The
homogenized lysates were centrifuged at 20,000 g at 4 °C, and protein
analyses were performed as described below. Protein concentrations
were determined according to Bradford (25).
Tissue Processing for Immune Complex Kinase Assays and Western
Blot Analysis—Rat livers were perfused for 130 min with isoosmotic
perfusion medium, thereafter with hypoosmotic perfusion medium (185
mosmol/liter). The desired osmolarity was achieved by omission of 60
mM NaCl. When indicated, inhibitors were present for 30 min prior to
institution of hypoosmotic perfusion conditions or addition of amino
acids. For immune complex assay and Western blot determinations,
liver lobes from perfused liver were excised at the respective time points
(0, 2, 5, 10, 20, and 30 min after installation of hypoosmotic perfusion
conditions), dounced with an Ultraturrax (Janke & Kunkel, Staufen,
Germany) at 0 °C in lysis buffer containing 20 mmol/liter Tris-HCl (pH
7.4), 140 mmol/liter NaCl, 10 mmol/liter NaF, 10 mmol/liter sodium
pyrophosphate, 1% Triton X-100, 1 mmol/liter EDTA, 1 mmol/liter
EGTA, 1 mmol/liter sodium vanadate, 20 mmol/liter -glycerophos-
phate, and protease inhibitor mixture.
Immune Complex Kinase Assays and Western Blot Analysis—The
lysed samples from the perfused liver or hepatocytes were centrifuged
at 4 °C, and aliquots of the supernatant were incubated with 1.5 g of
an antibody recognizing Erk-1 and Erk-2 for 2 h at 4 °C. Immune
complexes were collected by using protein A-Sepharose 4B (Sigma),
washed three times with lysis buffer and four times with kinase buffer
(10 mmol/liter Tris-HCl (pH 7.4), 150 mmol/liter NaCl, 10 mmol/liter
MgCl2, and 0.5 mmol/liter dithiothreitol), and incubated with 1 mg/ml
MBP in the presence of 10 Ci [-32P]ATP for 30 min at 37 °C. The
reactions were stopped by adding 2 gel loading buffer, and activity of
Erk-2 was monitored via autoradiography after sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (12.5% gel). To perform SDS-PAGE
and Western blot analysis an identical volume of 2 gel loading buffer
containing 200 mmol/liter dithiothreitol (pH 6.8) was added to the
lysates. After heating to 95 °C for 5 min, the proteins were subjected to
SDS-PAGE (50 g protein/lane, 7.5% gels). Following electrophoresis,
gels were equilibrated with transfer buffer (39 mmol/liter glycine, 48
mmol/liter Tris-HCl, 0.03% SDS, 20% methanol). Proteins were trans-
ferred to nitrocellulose membranes using a semi-dry transfer apparatus
(Amersham Biosciences). Blots were blocked overnight in 1% bovine
serum albumin solubilized in 20 mmol/liter Tris-HCl, pH 7.5, contain-
ing 150 mmol/liter NaCl and 0.1% Tween 20 and then incubated for 3–4
h with antibodies raised against [Tyr(P)418]Src, [Tyr(P)529]Src, Src,
[Tyr(P)397]FAK, FAK, [Thr(P)180/Tyr(P)182]p38MAPK and p38 at a dilu-
tion of 1:5,000. Following washing and incubation for 2 h with horse-
radish peroxidase-coupled anti-rabbit-IgG antibody (1:10,000), the blots
were washed again and developed using enhanced chemiluminescent
detection (Amersham GmbH, Freiburg, Germany). Densitometric anal-
ysis was performed with the E. A. S. Y. RH system (Herolab, Wiesloch,
Germany).
Electron Microscopy—For electron microscopic morphometry, fixa-
tion of the liver lobes was performed as described previously (11) by
perfusion of glutaraldehyde (3%) in Krebs-Henseleit medium for 30 s.
From the fixed livers small cubes of 1 mm3 were cut, postfixed for 2 h
with 2% osmium tetroxide, 2% uranylacetate, and 1.5% lead citrate in
PBS buffer, dehydrated in a graded series of ethanol and embedded in
Epon 812. Thin sections for electron microscopy were placed on copper
grids, stained with uranyl acetate and lead citrate, and were examined
with a EM 900 electron microscope (Zeiss, Oberkochem, Germany).
Quantitative Evaluation of Intracellular Organelles—The auto-
phagic vacuoles were defined as bits of cytoplasm sequestered from the
remaining cytoplasm by one or two membranes. The morphology of
autophagic vacuoles has been described in detail elsewhere (26). The
square fields, which were defined by the copper grids (127 m  127
m) were used as test fields and systematically searched for autophagic
vacuoles at a magnification of 10,500. The area of cytoplasm that was
examined ranged between 7,000 and 12,000 m2 (n 6). The area of the
AV was measured at magnification 21,000. Low power electron mi-
crographs of the test fields were mounted, and the area of the hepato-
cytic cytoplasm was calculated by count pointing method (144 test
points). The fractional volume of autophagic vacuoles, which is defined
as the volume of autophagic vacuoles per volume of liver cell cytoplasm
(Vav/Vc) was calculated as described previously (10, 27).
Immunocytochemistry and Confocal Laser Microscopy—For indirect
immunofluorescence microscopy, rat livers were perfused for 120 min
under isoosmotic conditions, and liver lobes were instantly fixed for
cryosectioning in liquid nitrogen. When present, latrunculin B (2 mol/
liter) had been added 30 min prior to fixation of liver lobes. Liver
sections were obtained using a cryotom CM 350 S (Leica, Bensheim,
Germany) at a thickness of 5 m. Air-dried samples were fixed using for
10 min at 4 °C and washed five times with ice-cold PBS. Immediately
after washing samples were incubated with Phalloidin-FITC (Sigma) at
a dilution of 1:500 in PBS containing 5% bovine serum albumine for 2 h
at room temperature. Subsequently samples were washed again three
times with ice-cold PBS. Immunostained liver perfusion samples were
analyzed with a Leica TCS NT confocal laser scanning system (Leica,
Bensheim, Germany) DM IRB inverted microscope. Images were ac-
quired from a channel at a wavelength of 488 nm.
Materials—The integrin antagonistic GRGDSP and the inactive con-
trol peptide GRGESP were from Bachem (Heidelberg, Germany). The
Integrins and Osmosensing 27089
 at R
sch Cntr Julich Res library on August 6, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
antibody raised against Erk-1/Erk-2 was from Upstate (Charlottesville,
VA). Antibodies recognizing [Tyr(P)397]FAK, [Tyr(P)418]Src, [Tyr(P)529]-
Src and total Src were from BIOSOURCE (Camarillo, CA). Anti-
[Thr(P)180/Tyr(P)182]p38MAPK antibody was from Promega (Madison,
WI). The antibodies raised against total FAK and total p38 were from
Santa Cruz Biotechnology. [-32P]ATP, L-[4,5-3H]leucine, [3H]inulin,
and [14C]urea were from Amersham Biosciences. L-lactic acid was from
Roth (Karlsruhe, Germany). Glutaraldehyde was purchased from Serva
(Heidelberg, Germany). PP-2 was from Biomol (Plymouth, PA), and
PP-3 and latrunculin B were from Calbiochem (Bad Soden, Germany).
Dulbecco’s modified Eagle’s medium, fetal bovine serum, and gentam-
icin were purchased from Biochrom (Berlin, Germany). Fibronectin was
purchased from Invitrogen (Karlsruhe, Germany). Enzymes were from
Roche Applied Science. Insulin, dexamethasone, and glutamine were
from Sigma. Penicillin/streptomycin was from Invitrogen. All other
chemicals were from Merck (Darmstadt, Germany).
Statistics—Data from different perfusion experiments are given as
means  S.E. (number of independent experiments). Conditions were
compared by Student’s t test. Differences were considered significant at
p  0.05.
RESULTS
Involvement of Integrins and Src in Hypoosmotic Signal
Transduction—Hypoosmotic (185 mosmol/liter) liver perfusion
induced a transient Src phosphorylation on Tyr418, which was
maximal (2.8  0.6-fold, n  4) at about 2 min. The increase in
Src-Tyr418 phosphorylation was accompanied by a transient
dephosphorylation of Src on Tyr529. According to earlier find-
ings (10, 28), hypoosmolarity induced a transient activation of
the MAP kinases Erk-1/Erk-2 and p38, which was maximal
between 5 and 10 min (Fig. 1). Normoosmotic control perfu-
sions were without effect on Erk-1/Erk-2 and p38MAPK (10) and
neither altered Src phosphorylation on Tyr418 and Tyr529, nor
FAK phosphorylation on Tyr397 (Fig. 1).
Infusion of the integrin antagonistic peptide GRGDSP (10
mol/liter), but not the inactive analogue GRGESP (10 mol/
liter) prevented the hypoosmotic stimulation of Src-Tyr418
phosphorylation and activation of the MAP kinases Erk-1/
Erk-2 and p38 (Fig. 1B and Table 1). Likewise, PP-2 (250
nmol/liter), an inhibitor of Src kinases (29), abolished the hy-
poosmotic increase of Src-Tyr418 phosphorylation and activa-
tion of the MAP kinases (Fig. 1B and Table 1). In the presence
of the inhibitors no significant effect of hypoosmotic perfusion
on Src-Tyr529 phosphorylation could be observed (Table 1).
Further experiments were performed in isolated liver cells
plated on fibronectin. 48-h cultured cells were exposed to hy-
poosmotic (205 mosmol/liter) or normoosmotic (305 mosmol/
liter) medium for 2 min. Hypoosmolarity induced an 2.7 
FIG. 1. Activation of Src and MAP kinases by hypoosmotic hepatocyte swelling in perfused rat liver and its inhibition by Src
inhibitor PP-2 and the integrin receptor antagonistic peptide GRGDSP, but not its inactive analogue GRGESP. Livers from fed rats
were perfused for 130 min with isoosmotic perfusion medium. Then, osmolarity was lowered from 305 to 185 mosmol/liter (A). Liver samples were
taken immediately before (zero time point) and during perfusion with hypoosmotic medium (2, 5, 10, 20, and 30 min after onset of hypoosmotic
perfusion conditions). Infusion of inhibitors was started 30 min prior to installation of hypoosmolarity (B). Src-Tyr418 and Src-Tyr529 phosphoryl-
ation, dual p38 phosphorylation and FAK-Tyr397 phosphorylation were addressed by Western blot analyses using the respective phosphospecific
antibodies. In addition, expression of Src, FAK, and p38 was monitored by probing Western blots with antibodies recognizing the respective total
protein. Erk-1/Erk-2 activity was measured with an immune complex assay using MBP as a substrate. Representative results of 3–5 independent
experiments are shown.
TABLE I
Effects of the integrin antagonistic peptide GRGDSP, its inactive analogue GRGESP and the Src inhibitor PP-2 on hypoosmotic Src-Tyr418 and
dual phosphorylation of p38 and Erk-1/Erk-2 activation in perfused rat liver
Data are from perfused rat liver exposed to hypoosmotic perfusion medium (185 mosmol/liter), without further pretreatment or in the presence
of GRGDSP (10 mol/liter), GRGESP (10 mol/liter), or PP-2 (250 nmol/liter), as described in Fig. 1. Quantification was performed densitometri-
cally. Phosphorylation of Src-Tyr418, Src-Tyr529, and p38-Thr180/Tyr182 and Erk-1/Erk-2 activity under isoosmotic conditions at the zero time point
was set to one, and the maximal phosphorylation/activation observed following hypoosmotic exposure is given as a fraction thereof. Changes in
Src-Tyr418 and Src-Tyr529 phosphorylation and dual p38 phosphorylation were normalized to expression of the respective total protein. Data are
from 3–5 separate perfusion experiments and represent means  S.E.
Condition Inhibitor [Tyr(P)418]Src [Thr(P)180/Tyr(P)182]p38 [Tyr(P)529]Src Erk-1/Erk-2
Hypoosmotic None 2.8  0.6a 1.9  0.2a 0.7  0.1a 2.1  0.2a
Hypoosmotic GRGDSP 1.2  0.2b 1.1  0.1b 0.7  0.2 1.1  0.1b
Hypoosmotic GRGESP 2.1  0.3a 2.7  0.8c 0.6  0.2 1.7  0.1a
Hypoosmotic PP-2 1.1  0.2d 1.1  0.2b 0.7  0.2 1.1  0.1b
a Response significantly different from isoosmotic control (p  0.05).
b Response significantly different from the response evoked by hypoosmolarity in absence of inhibitory compounds (p  0.05).
c Response different from the isoosmotic control (p  0.06).
d Response significantly different from the response evoked by hypoosmolarity in absence of inhibitory compounds (p  0.07).
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0.6-fold increase of Src-Tyr418 phosphorylation, which was
blunted to 0.8  0.1- and 1.1  0.1-fold in the presence of
GRGDSP (250 mol/liter) or PP-2 (20 mol/liter), respectively
(n  5). In a similar way, GRGDSP and PP-2 reduced the
hypoosmotic p38 activation from 2.3  0.4-fold under hypoos-
motic control conditions to 0.9  0.1- and 1.3  0.2-fold (n  5)
in the presence of the respective inhibitors (Fig. 2). The find-
ings support the suggestion that direct rather than indirect
effects of GRGDSP and PP-2 account for the inhibitory effects
found in the intact liver.
The Integrin/Src System Is Involved in Regulatory Volume
Decrease—As shown recently, p38MAPK activation in response
to hypoosmotic cell swelling is also involved in regulatory vol-
ume decrease (RVD) (8), which manifests within about 10 min
of hypoosmotic exposure as a net K and Cl release from the
hepatocytes through Ba2-, DIDS-, and quinidine-sensitive ion
channels (30). This RVD response only partially restores cell
volume, and after its completion the cells are left in a slightly
swollen state (30). When perfused livers are suddenly exposed
to hypoosmotic fluid (225 mosmol/liter), a net K release of
12.2  0.5 mol/g of liver is observed, which is completed
within 415  11 s (Table 3), and the residual cell volume
increase after completion of RVD is 13.4  0.8% (Table 2). As
shown recently (8), inhibition of p38MAPK blunts and delays
this volume regulatory net K release and renders the cells in
a more swollen state. As shown in Table 2, prevention of swell-
ing-induced p38MAPK activation by GRGDSP or PP-2 rendered
the cells in a significantly more swollen state following hypoos-
motic exposure. Likewise, volume regulatory net K efflux was
significantly decreased and delayed in the presence of
GRGDSP and PP-2, compared with the presence of their inac-
tive analogues GRGESP and PP-3, respectively (Table 3).
These data suggest that the integrin/Src system is also in-
volved in triggering RVD via p38MAPK activation.
Role of the Integrin/Src System in Proteolysis Control by Cell
Volume—As shown previously (10, 11, 31, 32), hypoosmotic cell
swelling led to a rapid and transient inhibition of proteolysis in
perfused rat liver (Fig. 3) due to an inhibition of autophagic
vacuole formation. Upon normoosmotic reexposure, proteolysis
rate returned to baseline levels, indicating the reversibility of
the process. GRGDSP, a hexapeptide with integrin receptor
antagonistic activity (33), but not its inactive analogue
GRGESP, prevented the swelling-dependent decrease of auto-
phagic proteolysis in perfused rat liver (Fig. 3A). In the pres-
ence of GRGESP, the decrease of proteolysis upon hyposmolar
exposure (225 mosmol/liter) was 23.1  3.4% (n  6), whereas
GRGDSP reduced this effect by about 80% to 5.6  2.1% (n 
4). Also Src inhibition by PP-2 abolished the antiproteolytic
effect of hypoosmotic cell swelling. In the presence of PP-2,
hypoosmotic proteolysis inhibition was only 3.1  1.3% (n  4)
compared with an inhibition by 21.9  2.9% (n  3) in the
presence of PP-3, a biologically inactive analogue of PP-2 (Fig.
3B). Likewise, in the presence of a higher degree of hypoosmo-
larity (185 mosmol/liter), proteolysis inhibition was 33.2 
1.4% under control conditions (n  6) and was blunted to 9.6 
2.9% (n  4) in the presence of GRGDSP (10 mol/liter), an
inhibitory effect, which was not observed with GRGESP (hy-
poosmotic proteolysis inhibition 31.0  3.4% (n  3)). Neither
PP-3 nor GRGESP had any significant influence on swelling-
induced proteolysis inhibition.
Also under conditions of isoosmotic hepatocyte swelling, i.e.
by addition of amino acids, an involvement of integrin-depend-
ent Src activation in triggering the inhibition of autophagic
proteolysis could be demonstrated. Glutamine is known to ex-
ert its antiproteolytic action mainly via an increase in cell
hydration ((23, 31, 34), compare also Table 2). Whereas gluta-
mine inhibited proteolysis by 14.0 1.2% (n 6) under control
conditions (Fig. 4A), this effect was decreased to 3.9  1.0%
(n  4) in the presence of the integrin antagonistic peptide
FIG. 2. Sensitivity of hypoosmotic activation of Src and
p38MAPK toward inhibition by GRGDSP and PP-2 in cultured rat
hepatocytes. Liver parenchymal cells were isolated from livers of male
Wistar rats by collagenase perfusion. After a total cultivation time of
48 h, cells were starved for 4 h. After this time, cells were either exposed
to hypoosmolar (205 mosmol/liter) or normoosmotic control medium
(305 mosmol/liter) for 2 min. If present, inhibitors (GRGDSP (RGD) or
PP-2) had been added 4 h prior to installation of hypoosmotic condi-
tions. At the end of this treatment, medium was removed from the
culture, cells were immediately lysed and phosphorylation of Src-
Tyr418, and dual phosphorylation of p38 was addressed by Western blot
analysis as described in the legend to Fig. 1. Results were normalized to
total blotted protein, as measured by determination of total p38 and
Src. Representative results of 4–5 independent experiments are shown.
TABLE II
Cell hydration changes in perfused rat liver under the influence of anisoosmotic conditions and amino acids in presence or absence of the
integrin inhibitory peptide GRGDSP, its inactive analogue GRGESP, and the Src inhibitor PP-2
Livers from male, fed Wistar rats were perfused for 160 min. Hypotonic perfusion conditions or amino acid infusions were installed from 130 to
160 min. If present, inhibitors were infused 30 min prior to installation of hypotonic perfusion conditions or infusion of glutamine, glutamine plus
glycine or phenylalanine. Intracellular water space under control conditions was 551  10 l/g liver weight (n  28). Data refer to hydration
changes 30 min after institution of the respective challenges, i.e. after completion of volume regulatory ion fluxes. No detectable changes of cell
hydration were observed with GRGDSP (10 mol/liter), GRGESP (10 mol/liter) or PP-2 (250 nmol/liter). For experimental details, see “Exper-
imental Procedures.” In parentheses, the number of different perfusion experiments is given. Values are given as means  S.E. from independent
perfusion experiments.
Condition
Change of intracellular water space
Control GRGDSP GRGESP PP-2
% change of basal value
Hypotonic (80 mosmol/liter) 13.4  0.8 (11) 16.9  0.6 (8)a 12.9  2.0 (3) 17.3  0.7 (3)b
Hypotonic (120 mosmol/liter) 19.5  1.3 (13) 24.5  0.9 (4)b 20.0  2,7 (3) N.D.c
Glutamine (2 mmol/liter) 6.4  0.6 (3) 7.9  1.5 (3) N.D. 8.3  0.5 (3)
Glutamine  glycine (2 mmol/liter)d 22.9  1.9 (4) 24.0  3.0 (3) 21.9  2.9 (4) N.D.
Phenylalanine (2 mmol/liter) 0.8  0.3 (5) 1.0  0.8 (3) N.D. 1.2  1.0 (3)
a Significant difference from the respective control in the absence of inhibitors, p  0.05.
b p  0.01.
c ND, not determined.
d Livers from 24-h starved rats were used.
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GRGDSP (10 mol/liter). Likewise, in livers from 24-h starved
animals, in which the swelling potency of amino acids is in-
creased due to an up-regulation of concentrative amino acid
transport systems in the plasma membrane (35, 36), the strong
inhibition of proteolysis by glutamine glycine (2 mmol/liter,
each) by 34.6 0.8% (n 4) was diminished to 9.8 1.0% (n
3) in the presence of PP-2 (250 nmol/liter, Fig. 4B). This resid-
ual antiproteolytic activity of these amino acids in the presence
of PP-2 resembles that obtained after p38MAPK inhibition (10)
and is ascribed to ammonia formation during breakdown of
these amino acids with consecutive alkalinization of the deg-
radative compartments (34). In contrast to glutamine and
glycine, phenylalanine does not induce hepatocyte swelling
and its antiproteolytic action is p38MAPK-independent and
involves mechanisms distinct from hepatocyte swelling (10,
11, 32). As shown in Fig. 5, there was no effect of GRGDSP on
the antiproteolytic effect of phenylalanine. These data sug-
gest that dependence on the integrin/Src system is a feature
of proteolysis control by cell volume, but not of proteolysis
control in general, i.e. also by cell volume-independent
mechanisms.
Integrins are linked to the actin cytoskeleton (17). Thus, the
role of microfilaments in hypoosmotic signaling toward prote-
olysis inhibition was assessed after destruction of microfila-
ments by latrunculin B. Latrunculin B (2 mol/liter) induced
sustained cholestasis in perfused rat liver (Fig. 6A), and as
FIG. 3. Antiproteolytic effect of hypoosmolarity and its sensi-
tivity to the integrin receptor antagonist GRGDSP (A) and Src
inhibitor PP-2 (B) in perfused rat liver. Livers from fed rats were
prelabeled in vivo by intraperitoneal injection of 150 Ci of [3H]leucine,
and 3H label release into effluent was monitored as a measure of
hepatic proteolysis in liver perfusion experiments. Due to different
labeling of the animals in vivo, the release of radioactivity was set to 100%
during control conditions. Infusion of integrin antagonistic peptide
GRGDSP (Ref. 33, E) or its inactive analogue GRGESP () was started at
100 min of perfusion time (A). In B, either PP-2 (250 nmol/liter, ƒ), an
inhibitor of Src activation (29) or its inactive analogue PP-3 (250 nmol/
liter, () (50)) was infused 30 min prior to installation of hypoosmotic
perfusion conditions. Neither GRGDSP, GRGESP, PP-2, nor PP-3 had a
significant effect on basal proteolysis activity. Data are given as means 
S.E. and are from 4–5 separate perfusion experiments, respectively.
FIG. 4. Antiproteolytic effect of glutamine and glycine and its
abolition by GRGDSP and PP-2 in perfused rat liver. Conditions
were as shown in Fig. 3. Livers from fed rats were used in A. In the
presence of either GRGDSP (10 mol/liter, ) or GRGESP (10 mol/
liter, f), glutamine (2 mmol/liter) was infused for 30 min (A). Livers
from 24-h starved rats were used in B. In the presence of either PP-2
(250 nmol/liter, ƒ) or PP-3 (250 nmol/liter, ), glutamine plus glycine (2
mmol/liter, each) were infused for 30 min. Inhibitors were installed 30
min prior to infusion of amino acids. Results are from 3–4 experiments
for each condition, data are shown as means  S.E.
TABLE III
Influence of the integrin antagonistic peptide GRGDSP, the Src
inhibitor PP-2, and p38MAPK inhibitor SB 203 580 on the extent and
time course of cell volume regulatory net K release in response to
hypoosmotic exposure (225 mosmol/liter) of isolated perfused rat liver
Livers from male, fed Wistar rats were exposed to hypoosmotic per-
fusion medium (305 3 225 mosmol/liter) for 30 min. Inhibitors were
dissolved in Me2SO and were infused continously, starting 30 min prior
to installation of hypoosmotic perfusion conditions. Calculations of net
K fluxes and of duration of K release were made by planimetry as
described earlier (8). In control experiments, Me2SO (20 l/min) was
present. N denotes the number of different perfusion experiments.
Symbols, significant difference from control.
Condition Net K release K release time N
mol/g s
Control 12.2  0.5 415  11 5
GRGDSP (10 mol/liter) 7.6  0.4a 530  40b 8
GRGESP (10 mol/liter) 10.2  0.4c 395  19c 5
PP-2 (250 nmol/liter) 8.3  0.2d 651  43c 5
PP-3 (250 nmol/liter) 11.7  0.4c 458  18c 6
SB 203580 (250 nmol/liter) 6.7  0.3a 597  38a 6
a p  0.001.
b p  0.05.
c Not significant.
d p  0.01.
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shown in Fig. 7, microscopically polymerized actin was no
longer visible in immunofluorescence-labeled thin sections of
perfused rat liver. However, despite destruction of actin fila-
ments, in the presence of latrunculin the antiproteolytic effect
of hypoosmotic cell swelling was fully preserved (Fig. 6B).
These findings indicate that integrin-dependent proteolysis
regulation by cell swelling does not require the integrity of
microfilaments.
Sequestration of Autophagic Vacuoles—Morphometric anal-
ysis of electron micrographs (Table 4) from perfused rat liver
was performed under hypoosmotic conditions and in the pres-
ence of phenylalanine, a non-swelling amino acid with strong
antiproteolytic activity. Shifting ambient osmolarity from 305
(control) to 185 mosmol/liter (hypoosmotic) significantly de-
creased the fractional volume occupied by autophagic vacuoles
(Vav/Vc) within 30 min from 51.8  1.9  10
4 (n  7) by about
47% to 27.3  3.0  104 (n  6), indicating that hypoosmotic
proteolysis inhibition is due to an inhibition of autophagic
vacuole formation (10). The hypoosmolarity induced decrease of
Vav/Vc was fully suppressed by PP-2 (250 nmol/liter) and sig-
nificantly inhibited by GRGDSP (10 mol/liter), but not
GRGESP (10 mol/liter, Table 4). In line with the known
strong antiproteolytic effect of phenylalanine (37), which nei-
ther causes significant ammonia production nor changes of
liver cell hydration (10, 11, 32), phenylalanine also caused a
marked decrease of Vav/Vc (Table 4). The phenylalanine-de-
pendent decrease of autophagic vacuole formation, however,
was insensitive to inhibition by PP-2 (Table 4). In view of the
fact that the swelling-independent mechanisms of regulation of
protein degradation do not require intact microtubules (32) and
activation of p38MAPK (11) the data suggest that the swelling-
dependent (hypoosmolarity, glutamine, glycine) and swelling-
independent proteolysis regulation mechanisms (phenylala-
nine) converge at the level of formation of autophagic vacuoles
(sequestration step), with the former being mediated by inte-
grin-triggered Src-dependent p38MAPK activation, and the lat-
ter being integrin/Src-and p38MAPK-independent.
DISCUSSION
Cell hydration changes critically determine cell function by
initiating signal transduction (osmosignaling). Here evidence
is presented that integrins play a role in sensing hepatocyte
swelling induced by hypoosmolarity or amino acid accumula-
tion in perfused rat liver, i.e. an intact organ model authenti-
cally preserving hepatocyte polarity and three-dimensional an-
choring to the extracellular matrix. Based on experiments with
the fibronectin-derived hexapeptide GRGDSP (33) and the Src
inhibitor PP-2 (29), this study shows a role of integrin-medi-
ated activation of Src-type kinases as a trigger of p38MAPK and
Erk-1/Erk-2 activation by hepatocyte swelling (Figs. 1 and 2).
In line with this, the swelling-related reduction of autophago-
some volume (Table 4), proteolysis inhibition (Figs. 3 and 4)
and the RVD and cell swelling induced by hypoosmolarity
(Tables 2 and 3), which represent functional consequences of
p38MAPK activation, are blunted by the RGD peptide and PP-2,
respectively. Proteolysis inhibition by phenylalanine, which
does not involve cell swelling and p38MAPK (10) is insensitive to
the RGD peptide and PP-2 (Fig. 5), indicating that the inhibi-
tors do not generally interfere with the regulation of auto-
phagic proteolysis and specifically impair the swelling-related
signal transduction toward proteolysis.
In contrast to results from the isolated perfused rat liver (23)
and 24-h cultured rat hepatocytes (32), no antiproteolytic re-
FIG. 5. Lack of effect of integrin antagonistic peptide GRGDSP
on phenylalanine-dependent decrease of proteolysis in per-
fused rat liver. Conditions were as described in the legend to Fig. 3.
Livers from fed rats were perfused with isoosmotic perfusion medium.
Phenylalanine (2 mmol/liter) was present from 130–160 min. Either
GRGDSP (10 mol/liter, ) or GRGESP (10 mol/liter, ) were pres-
ent from the 100-min perfusion time. Results are from three experi-
ments for each condition. Data are shown as means  S.E.
FIG. 6. Effect of latrunculin B on taurocholate excretion and
bile flow under isoosmotic conditions (A) and proteolysis inhi-
bition by hypoosmolarity (B). In perfused rat liver, bile flow (f) and
taurocholate excretion into bile () in the presence of latrunculin B (0.5
mol/liter) were assessed by gravimetry and established tracer tech-
niques (A). Results are from three independent experiments. In livers
from rats that had been prelabeled in vivo with [3H]leucine, release of
3H label was followed as an indicator of hepatic proteolysis (B). Latrun-
culin B (2 mol/liter) was infused for 30 min prior to installation of
hypoosmolar perfusion conditions (225 mosmol/liter, E). In control ex-
periments (), hypoosmotic conditions were installed in absence of the
microfilament inhibitor. Results are from four independent experi-
ments each, and values reflect means  S.E.
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sponse to hypoosmolarity was found in freshly isolated sus-
pended rat hepatocytes (38). Likewise, hypoosmolarity acti-
vates Erk-1/Erk-2 in perfused rat liver (Refs. 8 and 10 and this
study) and cultured hepatocytes (39), but not in freshly isolated
cells (40). In view of the present study, the absence of MAP
kinase activation and proteolysis regulation by hypoosmolarity
in suspended, but not in 48-h cultured hepatocytes (Fig. 2) may
reflect a deficit in sensing hypoosmotic swelling due to the lack
of integrin-mediated adherence to the extracellular matrix. On
the other hand, in freshly isolated suspended hepatocytes hy-
poosmolarity activates PI 3-kinase leading to increased glyco-
gen and fatty acid synthesis (40, 41) and taurocholate uptake
(42). Further, hypoosmolarity sensitizes these cells to prote-
olyis inhibition by amino acids (38), which depends on riboso-
mal S6 phosphorylation in a rapamycin-sensitive manner (13).
This suggests that multiple osmosensing mechanism exist in
hepatocytes, which could be differentially linked to intracellu-
lar signaling pathways.
Although hypoosmotic swelling was shown to induce reorga-
nization of the actin cytoskeleton in isolated hepatocytes (43)
and FAK tyrosine phosphorylation in HepG2 hepatoma (44)
and intestine 407 cells (45) and FAK is involved in mechano-
sensing in fibroblasts (46), it seems questionable that actin
filaments and FAK play a role in integrin-mediated signaling
toward swelling-induced proteolyis inhibition in perfused rat
liver. Disruption of the actin cytoskeleton by cytochalasins
prevents integrin signaling toward FAK and Erk-1/Erk-2 in
NIH-3T3 cells (47), abolishes hypoosmotic FAK Tyr phospho-
rylation in HepG2 cells (44) and produces a pronounced cho-
lestasis in perfused rat liver (32). However, cytochalasin treat-
FIG. 8. Hypothetical scheme of proteolysis regulation by cell
volume in liver.
TABLE IV
Effects of hypoosmotic exposure and phenylalanine on fractional
volume (Vav/Vc) of autophagic vacuoles (AVs) in the perfused
rat liver in presence of the integrin antagonistic peptide GRGDSP,
its inactive analogue GRGESP, the Src inhibitor PP-2, or the
p38MAPK inhibitor SB 203580
Livers from fed male Wistar rats were perfused in an open non-
recirculating manner for a total time of 160 min. Hypotonic perfusion
medium (185 mosmol/liter) or phenylalanine infusion (2 mmol/liter)
was installed from 130 to 160 min. At 160 min the livers were perfused
with 3% glutaraldehyde for 30 s and tissues were further processed for
transmission electron microscopy. When present, inhibitors, i.e.
GRGDSP (10 mol/liter), its inactive analogue GRGESP (10 mol/liter),
Src inhibitor PP-2 (250 nmol/liter) or p38MAPK inhibitor SB 203580 (250
nmol/liter) were started 30 min prior to hypoosmolarity or amino acid
infusion and infused from 100 to 160 min. Results are expressed as
fractional autophagic vacuole volume, which is defined as the volume of
AVs per cytoplasmic volume (Vav/Vc). Data are given as means S.E. N,
the number of experiments. Significance was calculated by means of
Student’s t test. Symbols are significance versus respective isoosmotic
control in the absence of amino acids.
Condition Inhibitor Vav/Vc  10
4 N
Control Absent 51.8  1.9 7
Hypoosmotic Absent 27.3  3.0a 6
GRGDSP 43.4  4.1b 4
GRGESP 24.3  2.3a 3
PP-2 51.4  8.0b 3
SB 203 580c 53.0  6,9b 3
Phenylalanine Absent 28.4  3.9a 3
PP-2 21.7  3.3a 4
a p  0.001.
b Not significant.
c Data from Ref. 10.
FIG. 7. The effect of latrunculin B (2 mol/liter) on microfila-
ments in perfused rat liver. Morphological analysis of the distribu-
tion of actin G was obtained in slices from perfused rat liver by freeze
sectioning under control conditions after a 90-min isoosmotic perfusion
period without inhibitor (A, C, E) or after prior infusion of latrunculin
B (2 mol/liter) from 60 to 90 min perfusion time (B, D, F). Microfila-
ments were visualized by means of immunofluorescence labeling with
phalloidin-targeted mouse anti-actin-G antibodies. Representative re-
sults are shown from three independent perfusion experiments for each
condition and show native transmission microscopic views (A and B,
magnification 43), projection scans (C and D, magnification 43), and
enlarged pericellular areas (E and F, magnification 128). For further
details, see “Experimental Procedures.”
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ment does not interfere with the antiproteolytic response to
hypoosmolarity in the latter system (32). Likewise, latrunculin
B, which disturbs actin organization by a mechanism distinct
from that of cytochalasins, induces cholestasis and disrupts the
actin cytoskeleton in perfused rat liver but does not impair
hypoosmotic proteolysis inhibition (Figs. 6 and 7). Secondly,
[Tyr(P)397]FAK phosphorylation, which is present already un-
der normoosmotic conditions in perfused rat liver, does not
increase in response to hypoosmolarity (Fig. 1). Finally, livers
are perfused in absence of serum, a condition known to prevent
Src recruitment by FAK (17). FAK-dependent and independent
pathways of Src activation are triggered by integrins (17) and
such independent pathways are apparently involved in swell-
ing-induced MAP kinase signaling toward proteolysis inhibi-
tion under the conditions employed in the present study. Po-
tential integrin partners in osmosensing and signaling include
tetraspan proteins such as the osmotically regulated CD9 (48)
and caveolin, which mediates the hypoosmotic activation of
volume regulatory anion channels in endothelial cells (49). A
link of integrins to the microtubular system may also play a
role in generating antiproteolytic signals apart from/down-
stream of hypoosmotic p38MAPK activation.
Our current working hypothesis is outlined in Fig. 8. Inte-
grins sense hepatocyte swelling, leading to activation of Src-
type kinases, which in turn mediate activation of Erk-1/Erk-2
and p38MAPK. Impairment of integrin-matrix interaction and
inhibition of Src-type kinases, but not disruption of the actin
cytoskeleton prevents the p38MAPK-dependent inhibition of au-
tophagy due to cell swelling and the regulatory volume de-
crease triggered by hypoosmolarity. Thus, integrins may act as
cell volume sensors at least in response to hepatocyte swelling.
As in bacteria, plants, and fungi (16), multiple osmosensing
mechanisms probably also exist in mammalian cells, and fu-
ture work will reveal their relative contributions.
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